ZIMBUS Trademark

Trademark Overview

On Monday, August 25, 2008, a trademark application was filed for ZIMBUS with the United States Patent and Trademark Office. The USPTO has given the ZIMBUS trademark a serial number of 79060776. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, August 26, 2018. This trademark is owned by Novartis AG. The ZIMBUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders for use in dermatology, oncology, haematology and in tissue and organ transplantation, in ophthalmology, and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; for the treatment of bacteria-based diseases; for the treatment of diabetes, anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations
zimbus

General Information

Serial Number79060776
Word MarkZIMBUS
Filing DateMonday, August 25, 2008
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, August 26, 2018
Registration Number3639888
Registration DateTuesday, June 16, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 31, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders for use in dermatology, oncology, haematology and in tissue and organ transplantation, in ophthalmology, and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; for the treatment of bacteria-based diseases; for the treatment of diabetes, anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 22, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events

Event DateEvent Description
Friday, March 22, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, March 22, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, May 12, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Saturday, February 25, 2017GENERIC MADRID TRANSACTION SENT TO IB
Saturday, February 25, 2017GENERIC MADRID TRANSACTION CREATED
Thursday, September 22, 2016TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, January 22, 2016CANCELLED SECTION 71
Saturday, April 13, 2013NEW REPRESENTATIVE AT IB RECEIVED
Saturday, February 23, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, December 11, 2009FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, September 25, 2009FINAL DISPOSITION NOTICE SENT TO IB
Friday, September 25, 2009FINAL DISPOSITION PROCESSED
Thursday, September 17, 2009FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, June 27, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, June 27, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 16, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, March 31, 2009PUBLISHED FOR OPPOSITION
Wednesday, March 11, 2009NOTICE OF PUBLICATION
Friday, February 20, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, February 20, 2009ASSIGNED TO LIE
Friday, February 13, 2009REFUSAL PROCESSED BY IB
Thursday, February 12, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 12, 2009EXAMINER'S AMENDMENT ENTERED
Thursday, February 12, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 12, 2009EXAMINERS AMENDMENT E-MAILED
Thursday, February 12, 2009EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 3, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 3, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 21, 2009NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, January 21, 2009REFUSAL PROCESSED BY MPU
Sunday, January 18, 2009NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, January 17, 2009NON-FINAL ACTION WRITTEN
Wednesday, December 17, 2008NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Saturday, December 13, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, December 12, 2008NON-FINAL ACTION WRITTEN
Wednesday, December 3, 2008ASSIGNED TO EXAMINER
Friday, November 28, 2008APPLICATION FILING RECEIPT MAILED
Monday, November 24, 2008NEW APPLICATION ENTERED IN TRAM
Friday, November 21, 2008LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Thursday, November 20, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

zimbus system treatment preparations disorders pharmaceutical diseases prevention ocular transplantation bacteria